ATI RN
ATI Fluid and Electrolytes
1. Which of the following organs does not contribute to fluid output from the body?
- A. Lungs
- B. Skin
- C. Intestine
- D. Lungs, skin, and intestine
Correct answer: D
Rationale: The correct answer is D. All the listed organs (lungs, skin, and intestines) contribute to fluid loss from the body. Lungs contribute to fluid loss through respiration, skin through sweating, and intestines through excretion. Therefore, none of the organs listed in the options retain fluids within the body. Choices A, B, and C are incorrect because all of these organs play a role in fluid output from the body.
2. Which electrolyte imbalance is most concerning in a patient taking digoxin?
- A. Monitor potassium levels
- B. Monitor calcium levels
- C. Monitor sodium levels
- D. Monitor magnesium levels
Correct answer: A
Rationale: The correct answer is to monitor potassium levels. Patients taking digoxin are at risk of developing toxicity due to hypokalemia. Low potassium levels can potentiate the toxic effects of digoxin on the heart, leading to serious arrhythmias. Monitoring calcium levels (Choice B) is not the primary concern in patients taking digoxin. While calcium levels play a role in cardiac function, hypocalcemia is not directly associated with digoxin toxicity. Monitoring sodium levels (Choice C) is important for other conditions but is not the primary concern in a patient taking digoxin. Monitoring magnesium levels (Choice D) is also essential, but hypomagnesemia is not as directly linked to digoxin toxicity as hypokalemia.
3. Low levels of high-density lipoproteins (HDL) are?
- A. associated with being underweight
- B. more prevalent in males
- C. highly predictive of CHD risk
- D. not a good predictor of CHD risk
Correct answer: C
Rationale: Low levels of HDL cholesterol are a strong predictor of coronary heart disease (CHD) risk because HDL helps to remove excess cholesterol from the bloodstream. Choice A is incorrect because low HDL levels are not associated with being underweight but rather with increased CHD risk. Choice B is incorrect as low HDL levels are not more prevalent in males but can affect both genders. Choice D is incorrect as low levels of HDL are indeed a good predictor of CHD risk.
4. A nurse sees a healthcare provider administer an incorrect medication dose but does not report the error. What should the nurse do first?
- A. Ignore the situation and continue with patient care.
- B. Report the error to the nurse manager immediately.
- C. Speak to the healthcare provider directly about the error.
- D. File an anonymous report to avoid conflict.
Correct answer: B
Rationale: When a nurse witnesses a healthcare provider administering an incorrect medication dose, the first step should be to report the error to the nurse manager immediately. Reporting medication errors is crucial for patient safety as it allows prompt intervention to prevent harm. Choice A is incorrect as ignoring the situation can jeopardize patient safety. Choice C, while addressing the error directly, may not ensure proper documentation and follow-up. Choice D, filing an anonymous report, is not as effective as directly informing the nurse manager who can take appropriate action and follow-up on the incident.
5. A nurse administers insulin for a misread glucose level. What should the nurse monitor for?
- A. Monitor for hypoglycemia
- B. Monitor for hyperglycemia
- C. Monitor for hyperkalemia
- D. Document the incident
Correct answer: A
Rationale: When a nurse administers insulin for a misread glucose level, they should monitor for hypoglycemia. Insulin lowers blood sugar levels, so the patient may experience hypoglycemia if given insulin unnecessarily. Monitoring for hypoglycemia involves observing for symptoms such as shakiness, sweating, dizziness, confusion, and palpitations. Choices B and C are incorrect because administering insulin for a misread glucose level would lower blood sugar levels, resulting in hypoglycemia, not hyperglycemia or hyperkalemia. Choice D is not the immediate priority; the focus should be on patient safety and monitoring for potential adverse effects of the unnecessary insulin.
Similar Questions
Access More Features
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $69.99
ATI Basic
- 50,000 Questions with answers
- All ATI courses Coverage
- 90 days access @ $149.99